We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+7.33%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$12.7B
AUM Growth
-$159M
Cap. Flow
+$1.08B
Cap. Flow %
8.52%
Top 10 Hldgs %
10.09%
Holding
527
New
73
Increased
203
Reduced
139
Closed
69

Top Sells

Rank Stock Value
1
BURL icon
Burlington
BURL
+$70.3M
2
WCN
Waste Connections
WCN
+$61.3M
3
AYI icon
Acuity Brands
AYI
+$56.2M
4
JBLU icon
JetBlue
JBLU
+$54.3M
5
MLM icon
Martin Marietta Materials
MLM
+$53.3M

Sector Composition

Rank Sector Weight
1 Healthcare 19.28%
2 Technology 18.45%
3 Industrials 14.15%
4 Consumer Discretionary 14.07%
5 Financials 10.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
251
UnitedHealth
UNH
$382B
$15.5M 0.12%
+63,300
New +$15.2M
LEA icon
252
Lear
LEA
$7.39B
$15.5M 0.12%
83,275
+36,500
+78% +$7.14M
EVR icon
253
Evercore
EVR
$11.8B
$15.5M 0.12%
146,625
+29,175
+25% +$3.01M
ALSN icon
254
Allison Transmission
ALSN
$9.51B
$15.4M 0.12%
381,550
+211,375
+124% +$8.7M
BBY icon
255
Best Buy
BBY
$19B
$15.4M 0.12%
206,575
+8,050
+4% +$595K
THO icon
256
Thor Industries
THO
$4.06B
$15.3M 0.12%
157,040
+5,035
+3% +$514K
WRB icon
257
W.R. Berkley
WRB
$28.1B
$15.2M 0.12%
706,472
+218,869
+45% +$4.87M
NVO
258
Novo Nordisk
NVO
$228B
$15M 0.12%
650,774
+33,756
+5% +$802K
CCI icon
259
Crown Castle
CCI
$34.6B
$14.9M 0.12%
138,633
-121,122
-47% -$12.6M
MDT icon
260
Medtronic
MDT
$112B
$14.9M 0.12%
174,071
+50,691
+41% +$4.23M
PVH icon
261
PVH
PVH
$4.07B
$14.8M 0.12%
98,925
+45,950
+87% +$7.23M
CLX icon
262
Clorox
CLX
$12B
$14.8M 0.12%
109,150
+49,450
+83% +$6.1M
PUK icon
263
Prudential
PUK
$36.4B
$14.7M 0.12%
331,163
-63,448
-16% -$3.1M
AZPN
264
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$14.7M 0.12%
157,975
+63,675
+68% +$5.91M
DY icon
265
Dycom Industries
DY
$11.2B
$14.6M 0.12%
154,981
-37,819
-20% -$3.87M
DEO icon
266
Diageo
DEO
$49.6B
$14.6M 0.12%
101,458
-10,086
-9% -$1.44M
SYY icon
267
Sysco
SYY
$40.8B
$14.6M 0.12%
213,885
-3,664
-2% -$234K
MTD icon
268
Mettler-Toledo International
MTD
$28.1B
$14.5M 0.11%
25,094
AEO icon
269
American Eagle Outfitters
AEO
$2.94B
$14.2M 0.11%
609,800
-69,600
-10% -$1.54M
PEP icon
270
PepsiCo
PEP
$196B
$14.2M 0.11%
130,090
-2,229
-2% -$230K
SAIC icon
271
Saic
SAIC
$4.95B
$14.1M 0.11%
174,458
+6,800
+4% +$578K
NYT icon
272
New York Times
NYT
$12.6B
$14.1M 0.11%
+545,133
New +$12.8M
ABT icon
273
Abbott
ABT
$188B
$14M 0.11%
228,937
-3,922
-2% -$238K
HIG icon
274
Hartford Financial Services
HIG
$39.9B
$13.9M 0.11%
+271,600
New +$14.2M
GOOGL icon
275
Alphabet (Google) Class A
GOOGL
$4.12T
$13.8M 0.11%
+244,280
New +$13.3M

Similar funds

Carillon Tower Advisers's Q2 2018 Portfolio in Review

As of Q2 2018, Carillon Tower Advisers held 527 positions worth $12.7B, down 1.2% from $12.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Carillon Tower Advisers deployed $1.08B of net new capital in Q2 2018, opening 73 new positions and adding to 203 existing holdings. Its largest new stake was WW International: 726,252 shares worth $73.4M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Burlington, an estimated $70.3M trimmed.

  • Carillon Tower Advisers's largest Q2 2018 buy was WW International: 726,252 shares worth $73.4M.
  • Carillon Tower Advisers added most to Abiomed Inc in Q2 2018, an estimated $63.1M increase.
  • Carillon Tower Advisers's biggest Q2 2018 reduction was Burlington, cutting an estimated $70.3M.
  • Carillon Tower Advisers fully exited Acuity Brands in Q2 2018, selling an estimated $56.2M.
  • Carillon Tower Advisers's ten largest holdings make up 10% of its $12.7B portfolio in Q2 2018.
  • Carillon Tower Advisers opened 73 new positions and closed 69 in Q2 2018.
  • Carillon Tower Advisers's portfolio value fell 1.2% quarter-over-quarter to $12.7B.

Based on Carillon Tower Advisers's 13F filing for Q2 2018, filed 9 Aug 2018.